102 related articles for article (PubMed ID: 2719746)
1. Pharmacokinetics of fosfosal in rats and dogs.
Ramis J; Mis R; Forn J
Arzneimittelforschung; 1989 Jan; 39(1):74-7. PubMed ID: 2719746
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of fosfosal after single and multiple oral doses in man.
Ramis J; Torrent J; Mis R; Barbanoj M; Abadias M; Jane F; Forn J
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):421-7. PubMed ID: 3264273
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability study of fosfosal and codeine administered alone or in combination.
Ramis J; Gich I; Torrent J; Mis R; Jané F; Forn J
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):352-7. PubMed ID: 2777424
[TBL] [Abstract][Full Text] [Related]
4. [Distribution and pharmacokinetics of fosfosal (UR-1521)].
Rimbau V; López R; Fernández A; Forn J
Arch Farmacol Toxicol; 1981 Apr; 7(1):61-4. PubMed ID: 7325717
[No Abstract] [Full Text] [Related]
5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of pidotimod in rats and dogs.
Coppi G; Silingardi S
Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
12. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the new oral blood glucose-lowering agent (-)-2-(4-tert.-butylphenoxy)-7-(4-chlorophenyl)-heptanic acid sodium salt in mice, rats and dogs.
Heitzmann T; Neidlein R; Freund P; Strein K
Arzneimittelforschung; 1995 Aug; 45(8):868-72. PubMed ID: 7575749
[TBL] [Abstract][Full Text] [Related]
14. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
Nakamura A; Hirota T; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
18. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
19. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
Dalton JT; Meyer MC; Golub AL
Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
